David L. Spector
Professor
Robert B. Gardner Jr., Professor
Cancer Center Member
Ph.D., Rutgers University, 1980
[email protected] | 516-367-8456
The immense amount of DNA, RNA and proteins that contribute to our genetic programs are precisely organized inside the cell's nucleus. My group studies how nuclear organization impacts gene regulation, and how misregulation of non-coding RNAs contributes to human diseases such as cancer.
David L. Spector鈥檚 laboratory is focused on characterizing long non-coding RNAs (lncRNAs) that exhibit altered levels of expression in breast cancer progression and during embryonic stem cell differentiation. A major focus of their efforts has been on Malat1 lncRNA, which is one of the most abundant lncRNAs. The Spector lab previously identified a novel mechanism of 3鈥-end processing of this RNA. More recent studies have revealed that increased levels of Malat1 lncRNA impacts breast cancer progression and metastasis. Knockout or antisense oligonucleotide knockdown of Malat1 results in the differentiation of mammary tumors and a significant reduction in metastasis. Studies are currently under way to elucidate the mechanism of action of this abundant nuclear retained lncRNA and to implement innovative therapeutic approaches that can impact its function in vivo. In addition, they have developed and genomically and transcriptomically characterized patient-derived breast tumor organoid models from patients with triple negative breast cancer or invasive lobular carcinoma of the breast. These models are being used to identify and characterize additional lncRNAs that are over-expressed in breast cancer. Several candidates will be pursued at the functional level and as new therapeutic targets, as well as for drug development and screening in a patient-specific manner.
A second area of study in the Spector lab is focused on identifying and characterizing lncRNAs that play critical roles in pluripotency and/or lineage commitment, and to identify the specific pathways that they regulate. To do so they have reanalyzed the raw data from their previously published differential RNA-seq screen comparing lncRNA expression in na茂ve mouse embryonic stem cells (mESCs) vs neural progenitor cells (NPCs). They prioritized transcripts that were more than 2-fold upregulated in mESCs compared to NPCs. This resulted in the identification of 147 mESC specific transcripts of which 105 have potential human orthologs. From this analysis several exciting candidates have been prioritized and are being pursued at the functional level. These studies will provide new insights as to how regulatory signals instructed by lncRNAs can impact pluripotency and/or lineage commitment which will influence basic biology and/or disease states.
Breast cancer case study could inform clinical trials
November 10, 2025
CSHL researchers examined tissue samples from a 59-year-old woman diagnosed with stage 1 triple-negative breast cancer.
Special edition: Breast Cancer Awareness Month
October 23, 2025
CSHL Professor David Spector discusses some of his lab鈥檚 latest research and the partnership making it possible.
Inspiring breast cancer breakthroughs
August 18, 2025
For World Breast Cancer Research Day, see how CSHL scientists are leading the charge against this all-too-common disease.
A new 鈥渓ink鈥 to triple-negative breast cancer
June 30, 2025
There鈥檚 no effective treatment for the deadly disease. A discovery by CSHL Professor David Spector and grad student Wenbo Xu could point to the first.
Joshua-Tor named CSHL Director of Research
January 2, 2024
The 黑料吃瓜资源 professor and HHMI investigator steps into her new role effective January 2, 2024.
Test your breast cancer awareness
October 18, 2023
Awareness is key to prevention and potential future treatments. Take this quiz to find out about the latest in breast cancer research at CSHL.
Cancer lab makes surprise discoveries in heart disease
November 30, 2022
Two separate studies from the Spector lab at CSHL suggest that certain genes can lead to cardiac problems.
Can cancer be treated by changing its cells?
April 11, 2022
Tumors grow when cells lose their biological identity. A promising therapeutic might restore their sense of self.
Paving a path to triple-negative breast cancer treatment
March 29, 2022
Researchers collected a biobank of triple-negative breast cancer mini-tissues to search for new and potentially patient-specific treatments.
Regulatory RNAs promote breast cancer metastasis
December 22, 2020
A gene-regulating bit of RNA promotes breast cancer metastasis. Agents that destroy that RNA provide hope for a new drug.
Selected Publications
7 Nov 2022 | Developmental Cell | 57(21):2450-2468.e7
Hazra, Rasmani; Brine, Lily; Garcia, Libia; Benz, Brian; Chirathivat, Napon; Shen, Michael; Wilkinson, John; Lyons, Scott; Spector, David;  
18 Feb 2022 | Cancer Research
Bhatia, Sonam; Kramer, Melissa; Russo, Suzanne; Naik, Payal; Arun, Gayatri; Brophy, Kyle; Andrews, Peter; Fan, Cheng; Perou, Charles; Preall, Jonathan; Ha, Taehoon; Plenker, Dennis; Tuveson, David; Rishi, Arvind; Wilkinson, John; McCombie, W; Kostroff, Karen; Spector, David;  
27 Sep 2016 | Cell Reports | 17(1):261-274
Diermeier, Sarah; Chang, Kung-Chi; Freier, Susan; Song, Junyan; El Demerdash, Osama; Krasnitz, Alexander; Rigo, Frank; Bennett, C; Spector, David;  
2012 | Cell Reports | 2(1):111-123
Zhang, B; Arun, G; Mao, Y; Lazar, Z; Hung, G; Bhattacharjee, G; Xiao, X; Booth, C; Wu, J; Zhang, C; Spector, D;  
All Publications
3 Aug 2025 | bioRxiv
Julian, Linda; Crozier, Lisa; Lukow, Devon; Mishra, Sanat; Swamy, Aditi; Hagenson, Ryan; Sennhenn, Peter; Sausville, Erin; Mendelson, Brianna; Chuaqui, Claudio; Qiao, Lu; Vasudevan, Anand; Lin, Kuan-Ting; Bhatia, Sonam; Bertomeu, Thierry; Chatr-Aryamontri, Andrew; Zhang, Li; Rees, Matthew; Ronan, Melissa; Roth, Jennifer; Nottoli, Timothy; Bai, Suxia; Lakshmipathi, Jayalakshmi; Muthusamy, Viswanathan; Van Vranken, Jonathan; Gygi, Steven; Thompson, Sarah; Smith, Joan; Anderson, Kendall; Shah, Sanjana; Bindra, Ranjit; Akerman, Martin; Spector, David; Krainer, Adrian; Sheltzer, Jason;  
30 Jun 2025 | Molecular Cancer Research
Xu, Wenbo; Bhatia, Sonam; Sahin, Yunus; Spector, David;  
Aug 2024 | Nature Metabolism | 6(8):1529-1548
Qiu, Yijian; Stamatatos, Olivia; Hu, Qingting; Ruiter Swain, Jed; Russo, Suzanne; Sann, Ava; Costa, Ana; Violante, Sara; Spector, David; Cross, Justin; Lukey, Michael;  
26 Jul 2024 | Cancer Discovery
Klingbeil, Olaf; Skopelitis, Damianos; Tonelli, Claudia; Yoshimoto, Toyoki; Alpsoy, Aktan; Panepinto, Maria; Minicozzi, Francesca; Merrill, Joseph; Cafiero, Amanda; Aggarwal, Disha; Russo, Suzanne; Ha, Taehoon; Demerdash, Osama; Wee, Tse-Luen; Spector, David; Lyons, Scott; Tuveson, David; Cifani, Paolo; Vakoc, Christopher;  
17 Jun 2024 | Nature Genetics
Maia-Silva, Diogo; Cunniff, Patrick; Schier, Allison; Skopelitis, Damianos; Trousdell, Marygrace; Moresco, Philip; Gao, Yuan; Kechejian, Vahag; He, Xue-Yan; Sahin, Yunus; Wan, Ledong; Alpsoy, Aktan; Liverpool, Jynelle; Krainer, Adrian; Egeblad, Mikala; Spector, David; Fearon, Douglas; Dos Santos, Camila; Taatjes, Dylan; Vakoc, Christopher;  
28 Feb 2024 | bioRxiv
Klingbeil, Olaf; Skopelitis, Damianos; Tonelli, Claudia; Alpsoy, Aktan; Minicozzi, Francesca; Aggarwal, Disha; Russo, Suzanne; Ha, Taehoon; Demerdash, Osama; Spector, David; Tuveson, David; Cifani, Paolo; Vakoc, Christopher;  









